Dulcolax Laxative

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Dulcolax Laxative
Generic name
BISACODYL
Manufacturer
Chattem, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
919375cd-7646-4958-9e2b-cec2e1b2bd49
SPL ID
a2391b80-8592-44ff-af63-198d04d243ab
Version
3
Effective date
2026-02-26
Source export date
2026-09-28
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/f7d2b6e3f8600cd856280ab55a9c6fa54a642647191d164f9d1110e89f3f4097/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:15:47
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use ■ if you cannot swallow without chewing Ask a doctor before use if you have ■ stomach pain, nausea or vomiting ■ noticed a sudden change in bowel habits that lasts more than 2 weeks When using this product ■ it may cause stomach discomfort, faintness and cramps ■ do not chew capsule(s) ■ do not use within 1 hour after taking an antacid or milk Stop use and ask a doctor if ■ you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition. ■ you need to use a laxative for more than 1 week If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.